Showing results (1571-1580 of 2,224) with videos related to

Sort By:
Pageof 223
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2019
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer ImmunotherapyXiaojing Shi, Qinqin Cheng, Tianling Hou, et al.
Physical Therapy|December 16, 2014
Descriptive data analysis examining how standardized assessments are used to guide post-acute discharge recommendations for rehabilitation services after strokeMarghuretta D Bland, Michelle Whitson, Hilary Harris, et al.
Neurogenetics|June 9, 2016
A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermiaTiago A Mestre, Andreea Manole, Heather MacDonald, et al.
Frontiers in Neurology|March 27, 2023
Study design challenges and strategies in clinical trials for rare diseases: Lessons learned from pantothenate kinase-associated neurodegenerationAleksandar Videnovic, Helle C V Pfeiffer, Anna Tylki-Szymańska, et al.
Movement Disorders Clinical Practice|January 31, 2024
Estimation of Ambulation and Survival in Neurodegeneration with Brain Iron Accumulation DisordersElahe Amini, Mohammad Rohani, Anthony E Lang, et al.
Frontiers in Psychiatry|November 17, 2022
Physician assisted-dying in mentally and somatically ill individuals in Switzerland: Protocol for survey-based studyEva Kowalinski, Tiziana Ziltener, Sarah Staub, et al.
Brain Structure & Function|September 9, 2017
[18F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSPSarah Coakeley, Sang Soo Cho, Yuko Koshimori, et al.
Journal of the American College of Surgeons|November 24, 2004
Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentationJulie E Lang, Laura J Esserman, Cheryl A Ewing, et al.
Ophthalmology|June 4, 2013
Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension studyGabriele E Lang, András Berta, Bora M Eldem, et al.
American Journal of Hematology|December 1, 1992
Proliferation of abnormal bone marrow histiocytes, an undesired effect of granulocyte macrophage-colony-stimulating factor therapy in a patient with Hurler's syndrome undergoing bone marrow transplantationE Lang, M L Cibull, V S Gallicchio, et al.
Pageof 223